|
Name |
3,4-diphenyl-5H-furan-2-one
|
Molecular Formula | C16H12O2 | |
IUPAC Name* |
3,4-diphenyl-2H-furan-5-one
|
|
SMILES |
C1C(=C(C(=O)O1)C2=CC=CC=C2)C3=CC=CC=C3
|
|
InChI |
InChI=1S/C16H12O2/c17-16-15(13-9-5-2-6-10-13)14(11-18-16)12-7-3-1-4-8-12/h1-10H,11H2
|
|
InChIKey |
CPBAHTZRJQATEJ-UHFFFAOYSA-N
|
|
Synonyms |
3,4-diphenyl-5H-furan-2-one; 5635-16-5; 3,4-Diphenylfuran-2(5H)-one; 3,4-diphenyl-2H-furan-5-one; 3,4-diphenyl-2,5-dihydrofuran-2-one; 3,4-diphenyl-2(5H)-furanone; CHEMBL1470821; NSC400730; Oprea1_147483; MLS001176843; SCHEMBL5071823; 2,3-diphenyl-2-buten-4-olide; DTXSID20322231; 3,4-diphenyl-2-(5H)-furanone; HMS2924F08; 3,4-diphenyl-2-(5H )-furanone; ZINC1593509; BDBM50033276; AKOS000117101; NSC-400730; SMR000591842; CS-0220371; EN300-06503; Z56943516
|
|
CAS | 5635-16-5 | |
PubChem CID | 344049 | |
ChEMBL ID | CHEMBL1470821 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 236.26 | ALogp: | 3.0 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 3 |
Heavy Atoms: | 18 | QED Weighted: | 0.738 |
Caco-2 Permeability: | -4.615 | MDCK Permeability: | 0.00002470 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.598 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.167 | Plasma Protein Binding (PPB): | 99.70% |
Volume Distribution (VD): | 0.659 | Fu: | 1.02% |
CYP1A2-inhibitor: | 0.981 | CYP1A2-substrate: | 0.111 |
CYP2C19-inhibitor: | 0.521 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.387 | CYP2C9-substrate: | 0.783 |
CYP2D6-inhibitor: | 0.082 | CYP2D6-substrate: | 0.473 |
CYP3A4-inhibitor: | 0.105 | CYP3A4-substrate: | 0.163 |
Clearance (CL): | 9.112 | Half-life (T1/2): | 0.341 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.076 |
Drug-inuced Liver Injury (DILI): | 0.963 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.36 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.083 | Carcinogencity: | 0.095 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.214 |
Respiratory Toxicity: | 0.16 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003032 | 0.521 | D05VLS | 0.620 | ||||
ENC004517 | 0.494 | D0M9DC | 0.500 | ||||
ENC004519 | 0.494 | D0E4DW | 0.421 | ||||
ENC004518 | 0.494 | D08FTG | 0.417 | ||||
ENC000321 | 0.482 | D0B1FE | 0.408 | ||||
ENC003342 | 0.458 | D0G1VX | 0.408 | ||||
ENC000732 | 0.449 | D09VXM | 0.395 | ||||
ENC000093 | 0.446 | D04DXN | 0.382 | ||||
ENC001109 | 0.440 | D0QV5T | 0.378 | ||||
ENC003697 | 0.427 | D0Y7EM | 0.375 |